Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SnoRNAs and miRNAs Networks Underlying COVID-19 Disease Severity.
Parray A, Mir FA, Doudin A, Iskandarani A, Danjuma MM, Kuni RAT, Abdelmajid A, Abdelhafez I, Arif R, Mulhim M, Abukhattab M, Dar SR, Moustafa AA, Elkord E, Al Khal AL, Elzouki AN, Cyprian F. Parray A, et al. Among authors: abdelmajid a. Vaccines (Basel). 2021 Sep 23;9(10):1056. doi: 10.3390/vaccines9101056. Vaccines (Basel). 2021. PMID: 34696164 Free PMC article.
Complement C5a and Clinical Markers as Predictors of COVID-19 Disease Severity and Mortality in a Multi-Ethnic Population.
Cyprian FS, Suleman M, Abdelhafez I, Doudin A, Masud Danjuma M, Mir FA, Parray A, Yousaf Z, Siddiqui MYA, Abdelmajid A, Mulhim M, Al-Shokri S, Abukhattab M, Shaheen R, Elkord E, Al-Khal AL, Elzouki AN, Girardi G. Cyprian FS, et al. Among authors: abdelmajid a. Front Immunol. 2021 Dec 13;12:707159. doi: 10.3389/fimmu.2021.707159. eCollection 2021. Front Immunol. 2021. PMID: 34966381 Free PMC article.
Effect of pioglitazone on inflammatory response and clinical outcome in T2DM patients with COVID-19: a randomized multicenter double-blind clinical trial.
Baagar K, Alessa T, Abu-Farha M, Abubaker J, Alhumaidi H, Franco Ceruto JA, Hamad MK, Omrani A, Abdelrahman S, Zaka-Ul Haq M, Safi AW, Alhariri B, Barman M, Abdelmajid A, Cancio HVD, Elmekaty E, Al-Khairi I, Cherian P, Jayyousi L, Ahmed M, Qaddoumi M, Hajji S, Esmaeel A, Al-Andaleeb A, Channanath A, Devarajan S, Ali H, Thanaraj TA, Al-Sabah S, Al-Mulla F, Abdul-Ghani M, Jayyousi A. Baagar K, et al. Among authors: abdelmajid a. Front Immunol. 2024 Sep 6;15:1369918. doi: 10.3389/fimmu.2024.1369918. eCollection 2024. Front Immunol. 2024. PMID: 39308871 Free PMC article. Clinical Trial.
HIV case reporting and HIV treatment outcomes in Qatar.
Farag E, Bozicevic I, Tartour AI, Nasreldin H, Daghfal J, Himatt S, Sallam MA, Ismail A, Al Shamali M, Coyle PV, Abdelmajid A, Al Mawlawi N, Al Thani MH, Al-Romaihi HE, Al Soub HAR, Al Maslamani M, Al Khal A. Farag E, et al. Among authors: abdelmajid a. Front Public Health. 2023 Nov 3;11:1234585. doi: 10.3389/fpubh.2023.1234585. eCollection 2023. Front Public Health. 2023. PMID: 38026435 Free PMC article.
Evaluation of anakinra in the management of patients with COVID-19 infection: A randomized clinical trial.
Elmekaty EZI, Maklad A, Abouelhassan R, Munir W, Ibrahim MIM, Nair A, Alibrahim R, Iqbal F, Al Bishawi A, Abdelmajid A, Aboukamar M, Hadi HA, Khattab MA, Al Soub H, Al Maslamani M. Elmekaty EZI, et al. Among authors: abdelmajid a. Front Microbiol. 2023 Jan 26;14:1098703. doi: 10.3389/fmicb.2023.1098703. eCollection 2023. Front Microbiol. 2023. PMID: 36778864 Free PMC article.
Adding colchicine to tocilizumab in hospitalized patients with severe COVID-19 pneumonia: An open-label randomized controlled trial.
Rahhal A, Najim M, Aljundi AH, Mahfouz A, Alyafei SM, Awaisu A, Habib MB, Obeidat I, Faisal MM, Alanzi MA, Nair AP, Elhassan A, Al-Dushain A, Abdelmajid AA, Abdelgader AE, Moursi AMA, Alharafsheh AEN, Kamar MRA, Goravey W, Omar AS, Abukhattab M, Khatib MY, Mohamedali MG, AlMaslamani MAR, Alemadi S. Rahhal A, et al. Among authors: abdelmajid aa. Medicine (Baltimore). 2022 Sep 30;101(39):e30618. doi: 10.1097/MD.0000000000030843. Medicine (Baltimore). 2022. PMID: 36181009 Free PMC article. Clinical Trial.
Favipiravir for the treatment of coronavirus disease 2019 pneumonia; a propensity score-matched cohort study.
Alattar RA, Abdalla S, Abdallah T, Kazman R, Qadmour A, Ibrahim T, Alhariri B, Shaar SH, Bajwa A, Alimam A, Qazi R, Ben Abid F, Daghfal J, Eldeeb A, Shukri K, Elsayed A, Rustom F, Alsamawi M, Abdelmajid A, Basulto MAP, Cobian AAR, Abukhattab M, Alkhal A, Almaslamani MA, Omrani AS. Alattar RA, et al. Among authors: abdelmajid a. J Infect Public Health. 2022 Oct;15(10):1061-1064. doi: 10.1016/j.jiph.2022.08.011. Epub 2022 Aug 27. J Infect Public Health. 2022. PMID: 36087547 Free PMC article.
15 results